ABG

Ally Bridge Group Portfolio holdings

AUM $114M
1-Year Est. Return 41.64%
This Quarter Est. Return
1 Year Est. Return
+41.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
+$11.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$10.1M
2
+$4.93M
3
+$4.91M
4
SLNO icon
Soleno Therapeutics
SLNO
+$4.89M
5
CMPS
Compass Pathways
CMPS
+$4.16M

Top Sells

1
+$12.4M
2
+$8.41M
3
+$6.57M
4
TRVI icon
Trevi Therapeutics
TRVI
+$4.32M
5
INSM icon
Insmed
INSM
+$3.76M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
1
DELISTED
Verona Pharma
VRNA
$15.2M 12.65%
160,701
+21,634
SLNO icon
2
Soleno Therapeutics
SLNO
$3.48B
$15M 12.47%
178,819
+58,370
LENZ
3
LENZ Therapeutics
LENZ
$1.16B
$10.1M 8.37%
+343,322
MRUS icon
4
Merus
MRUS
$7.19B
$7.37M 6.14%
140,208
+62,312
ELVN icon
5
Enliven Therapeutics
ELVN
$1.27B
$5.64M 4.7%
281,394
+111,620
ORIC icon
6
Oric Pharmaceuticals
ORIC
$1.24B
$4.93M 4.1%
+485,629
REPL icon
7
Replimune Group
REPL
$351M
$4.91M 4.09%
+528,491
TARS icon
8
Tarsus Pharmaceuticals
TARS
$3.08B
$4.91M 4.08%
121,182
-6,750
INSM icon
9
Insmed
INSM
$35B
$4.8M 4%
47,710
-37,400
MNMD icon
10
MindMed
MNMD
$1.04B
$4.71M 3.92%
726,172
+336,029
GERN icon
11
Geron
GERN
$766M
$4.58M 3.81%
3,251,475
+1,194,838
CMPS
12
Compass Pathways
CMPS
$626M
$4.16M 3.46%
+1,485,000
CNTA
13
Centessa Pharmaceuticals
CNTA
$3.09B
$3.86M 3.21%
293,986
+50,900
RNA icon
14
Avidity Biosciences
RNA
$6.99B
$3.77M 3.14%
+132,744
SLDB icon
15
Solid Biosciences
SLDB
$458M
$3.53M 2.93%
+724,000
LXEO icon
16
Lexeo Therapeutics
LXEO
$517M
$3.49M 2.9%
+867,302
PRAX icon
17
Praxis Precision Medicines
PRAX
$4B
$3.4M 2.83%
80,880
-14,702
TECX
18
Tectonic Therapeutic
TECX
$323M
$3.25M 2.71%
163,683
+31,461
KRRO icon
19
Korro Bio
KRRO
$396M
$1.93M 1.6%
154,223
+94,500
WHWK
20
Whitehawk Therapeutics
WHWK
$104M
$1.53M 1.27%
817,939
ATYR
21
aTyr Pharma
ATYR
$99.9M
$1.46M 1.21%
287,720
-489,300
MNPR icon
22
Monopar Therapeutics
MNPR
$494M
$1.24M 1.03%
+34,537
PMN icon
23
ProMIS Neurosciences
PMN
$23.5M
$646K 0.54%
1,334,428
-150,271
AXSM icon
24
Axsome Therapeutics
AXSM
$6.38B
– –
-72,113
BPMC
25
DELISTED
Blueprint Medicines
BPMC
– –
-74,192
1
2